| abstract |
The present invention relates to compounds, tautomers and pharmaceutically acceptable salts of the disclosed compounds, wherein the compound has the structure of formula I, and the variables R1 and R2 are as defined in the specification. The invention also discloses corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates. |